Global CRISPR Genome Editing Market Size, Status and Forecast 2024-2031

Report ID: 949789 | Published Date: Feb 2026 | No. of Page: 124 | Base Year: 2025 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global CRISPR Genome Editing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Genetic Engineering
        1.2.3 Gene Library
        1.2.4 Human Stem Cells
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global CRISPR Genome Editing Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Biotechnology Companies
        1.3.3 Pharmaceutical Companies
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global CRISPR Genome Editing Market Perspective (2016-2027)
    2.2 CRISPR Genome Editing Growth Trends by Regions
        2.2.1 CRISPR Genome Editing Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 CRISPR Genome Editing Historic Market Share by Regions (2016-2021)
        2.2.3 CRISPR Genome Editing Forecasted Market Size by Regions (2022-2027)
    2.3 CRISPR Genome Editing Industry Dynamic
        2.3.1 CRISPR Genome Editing Market Trends
        2.3.2 CRISPR Genome Editing Market Drivers
        2.3.3 CRISPR Genome Editing Market Challenges
        2.3.4 CRISPR Genome Editing Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top CRISPR Genome Editing Players by Revenue
        3.1.1 Global Top CRISPR Genome Editing Players by Revenue (2016-2021)
        3.1.2 Global CRISPR Genome Editing Revenue Market Share by Players (2016-2021)
    3.2 Global CRISPR Genome Editing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by CRISPR Genome Editing Revenue
    3.4 Global CRISPR Genome Editing Market Concentration Ratio
        3.4.1 Global CRISPR Genome Editing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by CRISPR Genome Editing Revenue in 2020
    3.5 CRISPR Genome Editing Key Players Head office and Area Served
    3.6 Key Players CRISPR Genome Editing Product Solution and Service
    3.7 Date of Enter into CRISPR Genome Editing Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR Genome Editing Breakdown Data by Type
    4.1 Global CRISPR Genome Editing Historic Market Size by Type (2016-2021)
    4.2 Global CRISPR Genome Editing Forecasted Market Size by Type (2022-2027)

5 CRISPR Genome Editing Breakdown Data by Application
    5.1 Global CRISPR Genome Editing Historic Market Size by Application (2016-2021)
    5.2 Global CRISPR Genome Editing Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America CRISPR Genome Editing Market Size (2016-2027)
    6.2 North America CRISPR Genome Editing Market Size by Type
        6.2.1 North America CRISPR Genome Editing Market Size by Type (2016-2021)
        6.2.2 North America CRISPR Genome Editing Market Size by Type (2022-2027)
        6.2.3 North America CRISPR Genome Editing Market Size by Type (2016-2027)
    6.3 North America CRISPR Genome Editing Market Size by Application
        6.3.1 North America CRISPR Genome Editing Market Size by Application (2016-2021)
        6.3.2 North America CRISPR Genome Editing Market Size by Application (2022-2027)
        6.3.3 North America CRISPR Genome Editing Market Size by Application (2016-2027)
    6.4 North America CRISPR Genome Editing Market Size by Country
        6.4.1 North America CRISPR Genome Editing Market Size by Country (2016-2021)
        6.4.2 North America CRISPR Genome Editing Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe CRISPR Genome Editing Market Size (2016-2027)
    7.2 Europe CRISPR Genome Editing Market Size by Type
        7.2.1 Europe CRISPR Genome Editing Market Size by Type (2016-2021)
        7.2.2 Europe CRISPR Genome Editing Market Size by Type (2022-2027)
        7.2.3 Europe CRISPR Genome Editing Market Size by Type (2016-2027)
    7.3 Europe CRISPR Genome Editing Market Size by Application
        7.3.1 Europe CRISPR Genome Editing Market Size by Application (2016-2021)
        7.3.2 Europe CRISPR Genome Editing Market Size by Application (2022-2027)
        7.3.3 Europe CRISPR Genome Editing Market Size by Application (2016-2027)
    7.4 Europe CRISPR Genome Editing Market Size by Country
        7.4.1 Europe CRISPR Genome Editing Market Size by Country (2016-2021)
        7.4.2 Europe CRISPR Genome Editing Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific CRISPR Genome Editing Market Size (2016-2027)
    8.2 Asia-Pacific CRISPR Genome Editing Market Size by Type
        8.2.1 Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific CRISPR Genome Editing Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2027)
    8.3 Asia-Pacific CRISPR Genome Editing Market Size by Application
        8.3.1 Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific CRISPR Genome Editing Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2027)
    8.4 Asia-Pacific CRISPR Genome Editing Market Size by Region
        8.4.1 Asia-Pacific CRISPR Genome Editing Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific CRISPR Genome Editing Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America CRISPR Genome Editing Market Size (2016-2027)
    9.2 Latin America CRISPR Genome Editing Market Size by Type
        9.2.1 Latin America CRISPR Genome Editing Market Size by Type (2016-2021)
        9.2.2 Latin America CRISPR Genome Editing Market Size by Type (2022-2027)
        9.2.3 Latin America CRISPR Genome Editing Market Size by Type (2016-2027)
    9.3 Latin America CRISPR Genome Editing Market Size by Application
        9.3.1 Latin America CRISPR Genome Editing Market Size by Application (2016-2021)
        9.3.2 Latin America CRISPR Genome Editing Market Size by Application (2022-2027)
        9.3.3 Latin America CRISPR Genome Editing Market Size by Application (2016-2027)
    9.4 Latin America CRISPR Genome Editing Market Size by Country
        9.4.1 Latin America CRISPR Genome Editing Market Size by Country (2016-2021)
        9.4.2 Latin America CRISPR Genome Editing Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa CRISPR Genome Editing Market Size (2016-2027)
    10.2 Middle East & Africa CRISPR Genome Editing Market Size by Type
        10.2.1 Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa CRISPR Genome Editing Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2027)
    10.3 Middle East & Africa CRISPR Genome Editing Market Size by Application
        10.3.1 Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa CRISPR Genome Editing Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2027)
    10.4 Middle East & Africa CRISPR Genome Editing Market Size by Country
        10.4.1 Middle East & Africa CRISPR Genome Editing Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa CRISPR Genome Editing Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Editas Medicine
        11.1.1 Editas Medicine Company Details
        11.1.2 Editas Medicine Business Overview
        11.1.3 Editas Medicine CRISPR Genome Editing Introduction
        11.1.4 Editas Medicine Revenue in CRISPR Genome Editing Business (2016-2021)
        11.1.5 Editas Medicine Recent Development
    11.2 CRISPR Therapeutics
        11.2.1 CRISPR Therapeutics Company Details
        11.2.2 CRISPR Therapeutics Business Overview
        11.2.3 CRISPR Therapeutics CRISPR Genome Editing Introduction
        11.2.4 CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021)
        11.2.5 CRISPR Therapeutics Recent Development
    11.3 Horizon Discovery
        11.3.1 Horizon Discovery Company Details
        11.3.2 Horizon Discovery Business Overview
        11.3.3 Horizon Discovery CRISPR Genome Editing Introduction
        11.3.4 Horizon Discovery Revenue in CRISPR Genome Editing Business (2016-2021)
        11.3.5 Horizon Discovery Recent Development
    11.4 Sigma-Aldrich
        11.4.1 Sigma-Aldrich Company Details
        11.4.2 Sigma-Aldrich Business Overview
        11.4.3 Sigma-Aldrich CRISPR Genome Editing Introduction
        11.4.4 Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2016-2021)
        11.4.5 Sigma-Aldrich Recent Development
    11.5 Genscript
        11.5.1 Genscript Company Details
        11.5.2 Genscript Business Overview
        11.5.3 Genscript CRISPR Genome Editing Introduction
        11.5.4 Genscript Revenue in CRISPR Genome Editing Business (2016-2021)
        11.5.5 Genscript Recent Development
    11.6 Sangamo Biosciences
        11.6.1 Sangamo Biosciences Company Details
        11.6.2 Sangamo Biosciences Business Overview
        11.6.3 Sangamo Biosciences CRISPR Genome Editing Introduction
        11.6.4 Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
        11.6.5 Sangamo Biosciences Recent Development
    11.7 Lonza Group
        11.7.1 Lonza Group Company Details
        11.7.2 Lonza Group Business Overview
        11.7.3 Lonza Group CRISPR Genome Editing Introduction
        11.7.4 Lonza Group Revenue in CRISPR Genome Editing Business (2016-2021)
        11.7.5 Lonza Group Recent Development
    11.8 Integrated DNA Technologies
        11.8.1 Integrated DNA Technologies Company Details
        11.8.2 Integrated DNA Technologies Business Overview
        11.8.3 Integrated DNA Technologies CRISPR Genome Editing Introduction
        11.8.4 Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2016-2021)
        11.8.5 Integrated DNA Technologies Recent Development
    11.9 New England Biolabs
        11.9.1 New England Biolabs Company Details
        11.9.2 New England Biolabs Business Overview
        11.9.3 New England Biolabs CRISPR Genome Editing Introduction
        11.9.4 New England Biolabs Revenue in CRISPR Genome Editing Business (2016-2021)
        11.9.5 New England Biolabs Recent Development
    11.10 Origene Technologies
        11.10.1 Origene Technologies Company Details
        11.10.2 Origene Technologies Business Overview
        11.10.3 Origene Technologies CRISPR Genome Editing Introduction
        11.10.4 Origene Technologies Revenue in CRISPR Genome Editing Business (2016-2021)
        11.10.5 Origene Technologies Recent Development
    11.11 Transposagen Biopharmaceuticals
        11.11.1 Transposagen Biopharmaceuticals Company Details
        11.11.2 Transposagen Biopharmaceuticals Business Overview
        11.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Introduction
        11.11.4 Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2016-2021)
        11.11.5 Transposagen Biopharmaceuticals Recent Development
    11.12 Thermo Fisher Scientific
        11.12.1 Thermo Fisher Scientific Company Details
        11.12.2 Thermo Fisher Scientific Business Overview
        11.12.3 Thermo Fisher Scientific CRISPR Genome Editing Introduction
        11.12.4 Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2016-2021)
        11.12.5 Thermo Fisher Scientific Recent Development
    11.13 Caribou Biosciences
        11.13.1 Caribou Biosciences Company Details
        11.13.2 Caribou Biosciences Business Overview
        11.13.3 Caribou Biosciences CRISPR Genome Editing Introduction
        11.13.4 Caribou Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
        11.13.5 Caribou Biosciences Recent Development
    11.14 Precision Biosciences
        11.14.1 Precision Biosciences Company Details
        11.14.2 Precision Biosciences Business Overview
        11.14.3 Precision Biosciences CRISPR Genome Editing Introduction
        11.14.4 Precision Biosciences Revenue in CRISPR Genome Editing Business (2016-2021)
        11.14.5 Precision Biosciences Recent Development
    11.15 Cellectis
        11.15.1 Cellectis Company Details
        11.15.2 Cellectis Business Overview
        11.15.3 Cellectis CRISPR Genome Editing Introduction
        11.15.4 Cellectis Revenue in CRISPR Genome Editing Business (2016-2021)
        11.15.5 Cellectis Recent Development
    11.16 Intellia Therapeutics
        11.16.1 Intellia Therapeutics Company Details
        11.16.2 Intellia Therapeutics Business Overview
        11.16.3 Intellia Therapeutics CRISPR Genome Editing Introduction
        11.16.4 Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021)
        11.16.5 Intellia Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global CRISPR Genome Editing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Genetic Engineering
    Table 3. Key Players of Gene Library
    Table 4. Key Players of Human Stem Cells
    Table 5. Key Players of Others
    Table 6. Global CRISPR Genome Editing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global CRISPR Genome Editing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global CRISPR Genome Editing Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global CRISPR Genome Editing Market Share by Regions (2016-2021)
    Table 10. Global CRISPR Genome Editing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global CRISPR Genome Editing Market Share by Regions (2022-2027)
    Table 12. CRISPR Genome Editing Market Trends
    Table 13. CRISPR Genome Editing Market Drivers
    Table 14. CRISPR Genome Editing Market Challenges
    Table 15. CRISPR Genome Editing Market Restraints
    Table 16. Global CRISPR Genome Editing Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global CRISPR Genome Editing Market Share by Players (2016-2021)
    Table 18. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2020)
    Table 19. Ranking of Global Top CRISPR Genome Editing Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by CRISPR Genome Editing Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players CRISPR Genome Editing Product Solution and Service
    Table 23. Date of Enter into CRISPR Genome Editing Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global CRISPR Genome Editing Revenue Market Share by Type (2016-2021)
    Table 27. Global CRISPR Genome Editing Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global CRISPR Genome Editing Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global CRISPR Genome Editing Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global CRISPR Genome Editing Revenue Market Share by Application (2016-2021)
    Table 31. Global CRISPR Genome Editing Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global CRISPR Genome Editing Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific CRISPR Genome Editing Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific CRISPR Genome Editing Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa CRISPR Genome Editing Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa CRISPR Genome Editing Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa CRISPR Genome Editing Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa CRISPR Genome Editing Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa CRISPR Genome Editing Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa CRISPR Genome Editing Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Editas Medicine Company Details
    Table 64. Editas Medicine Business Overview
    Table 65. Editas Medicine CRISPR Genome Editing Product
    Table 66. Editas Medicine Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 67. Editas Medicine Recent Development
    Table 68. CRISPR Therapeutics Company Details
    Table 69. CRISPR Therapeutics Business Overview
    Table 70. CRISPR Therapeutics CRISPR Genome Editing Product
    Table 71. CRISPR Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 72. CRISPR Therapeutics Recent Development
    Table 73. Horizon Discovery Company Details
    Table 74. Horizon Discovery Business Overview
    Table 75. Horizon Discovery CRISPR Genome Editing Product
    Table 76. Horizon Discovery Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 77. Horizon Discovery Recent Development
    Table 78. Sigma-Aldrich Company Details
    Table 79. Sigma-Aldrich Business Overview
    Table 80. Sigma-Aldrich CRISPR Genome Editing Product
    Table 81. Sigma-Aldrich Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 82. Sigma-Aldrich Recent Development
    Table 83. Genscript Company Details
    Table 84. Genscript Business Overview
    Table 85. Genscript CRISPR Genome Editing Product
    Table 86. Genscript Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 87. Genscript Recent Development
    Table 88. Sangamo Biosciences Company Details
    Table 89. Sangamo Biosciences Business Overview
    Table 90. Sangamo Biosciences CRISPR Genome Editing Product
    Table 91. Sangamo Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 92. Sangamo Biosciences Recent Development
    Table 93. Lonza Group Company Details
    Table 94. Lonza Group Business Overview
    Table 95. Lonza Group CRISPR Genome Editing Product
    Table 96. Lonza Group Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 97. Lonza Group Recent Development
    Table 98. Integrated DNA Technologies Company Details
    Table 99. Integrated DNA Technologies Business Overview
    Table 100. Integrated DNA Technologies Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 101. Integrated DNA Technologies Recent Development
    Table 102. New England Biolabs Company Details
    Table 103. New England Biolabs Business Overview
    Table 104. New England Biolabs CRISPR Genome Editing Product
    Table 105. New England Biolabs Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 106. New England Biolabs Recent Development
    Table 107. Origene Technologies Company Details
    Table 108. Origene Technologies Business Overview
    Table 109. Origene Technologies CRISPR Genome Editing Product
    Table 110. Origene Technologies Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 111. Origene Technologies Recent Development
    Table 112. Transposagen Biopharmaceuticals Company Details
    Table 113. Transposagen Biopharmaceuticals Business Overview
    Table 114. Transposagen Biopharmaceuticals CRISPR Genome Editing Product
    Table 115. Transposagen Biopharmaceuticals Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 116. Transposagen Biopharmaceuticals Recent Development
    Table 117. Thermo Fisher Scientific Company Details
    Table 118. Thermo Fisher Scientific Business Overview
    Table 119. Thermo Fisher Scientific CRISPR Genome Editing Product
    Table 120. Thermo Fisher Scientific Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 121. Thermo Fisher Scientific Recent Development
    Table 122. Caribou Biosciences Company Details
    Table 123. Caribou Biosciences Business Overview
    Table 124. Caribou Biosciences CRISPR Genome Editing Product
    Table 125. Caribou Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 126. Caribou Biosciences Recent Development
    Table 127. Precision Biosciences Company Details
    Table 128. Precision Biosciences Business Overview
    Table 129. Precision Biosciences CRISPR Genome Editing Product
    Table 130. Precision Biosciences Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 131. Precision Biosciences Recent Development
    Table 132. Cellectis Company Details
    Table 133. Cellectis Business Overview
    Table 134. Cellectis CRISPR Genome Editing Product
    Table 135. Cellectis Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 136. Cellectis Recent Development
    Table 137. Intellia Therapeutics Company Details
    Table 138. Intellia Therapeutics Business Overview
    Table 139. Intellia Therapeutics CRISPR Genome Editing Product
    Table 140. Intellia Therapeutics Revenue in CRISPR Genome Editing Business (2016-2021) & (US$ Million)
    Table 141. Intellia Therapeutics Recent Development
    Table 142. Research Programs/Design for This Report
    Table 143. Key Data Information from Secondary Sources
    Table 144. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global CRISPR Genome Editing Market Share by Type: 2020 VS 2027
    Figure 2. Genetic Engineering Features
    Figure 3. Gene Library Features
    Figure 4. Human Stem Cells Features
    Figure 5. Others Features
    Figure 6. Global CRISPR Genome Editing Market Share by Application: 2020 VS 2027
    Figure 7. Biotechnology Companies Case Studies
    Figure 8. Pharmaceutical Companies Case Studies
    Figure 9. Others Case Studies
    Figure 10. CRISPR Genome Editing Report Years Considered
    Figure 11. Global CRISPR Genome Editing Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global CRISPR Genome Editing Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global CRISPR Genome Editing Market Share by Regions: 2020 VS 2027
    Figure 14. Global CRISPR Genome Editing Market Share by Regions (2022-2027)
    Figure 15. Global CRISPR Genome Editing Market Share by Players in 2020
    Figure 16. Global Top CRISPR Genome Editing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CRISPR Genome Editing as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by CRISPR Genome Editing Revenue in 2020
    Figure 18. Global CRISPR Genome Editing Revenue Market Share by Type (2016-2021)
    Figure 19. Global CRISPR Genome Editing Revenue Market Share by Type (2022-2027)
    Figure 20. North America CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America CRISPR Genome Editing Market Share by Type (2016-2027)
    Figure 22. North America CRISPR Genome Editing Market Share by Application (2016-2027)
    Figure 23. North America CRISPR Genome Editing Market Share by Country (2016-2027)
    Figure 24. United States CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe CRISPR Genome Editing Market Share by Type (2016-2027)
    Figure 28. Europe CRISPR Genome Editing Market Share by Application (2016-2027)
    Figure 29. Europe CRISPR Genome Editing Market Share by Country (2016-2027)
    Figure 30. Germany CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific CRISPR Genome Editing Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific CRISPR Genome Editing Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific CRISPR Genome Editing Market Share by Region (2016-2027)
    Figure 40. China CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America CRISPR Genome Editing Market Share by Type (2016-2027)
    Figure 48. Latin America CRISPR Genome Editing Market Share by Application (2016-2027)
    Figure 49. Latin America CRISPR Genome Editing Market Share by Country (2016-2027)
    Figure 50. Mexico CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa CRISPR Genome Editing Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa CRISPR Genome Editing Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa CRISPR Genome Editing Market Share by Country (2016-2027)
    Figure 56. Turkey CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE CRISPR Genome Editing Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Editas Medicine Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 60. CRISPR Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 61. Horizon Discovery Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 62. Sigma-Aldrich Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 63. Genscript Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 64. Sangamo Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 65. Lonza Group Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 66. Integrated DNA Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 67. New England Biolabs Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 68. Origene Technologies Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 69. Transposagen Biopharmaceuticals Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 70. Thermo Fisher Scientific Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 71. Caribou Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 72. Precision Biosciences Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 73. Cellectis Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 74. Intellia Therapeutics Revenue Growth Rate in CRISPR Genome Editing Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Editas Medicine
CRISPR Therapeutics
Horizon Discovery
Sigma-Aldrich
Genscript
Sangamo Biosciences
Lonza Group
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Thermo Fisher Scientific
Caribou Biosciences
Precision Biosciences
Cellectis
Intellia Therapeutics
Frequently Asked Questions
CRISPR Genome Editing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CRISPR Genome Editing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CRISPR Genome Editing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Regenerative Drugs

Regenerative drugs are used to repair, replace, and regenerate tissues and organs affected by inj ... Read More